Pfizer slashes earnings forecast on decrease COVID gross sales, will lower prices
A corporate brand is noticed at a Pfizer administrative center in Puurs, Belgium, December 2, 2022. REUTERS/Johanna Geron/Record Photograph Achieve Licensing RightsOct 13 (Reuters) – Pfizer (PFE.N) on Friday slashed its full-year
